| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
N/A |
| Shares
Out: |
19,300,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$57.98 - $57.98 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wade Denis Newell |
Director |
– • – |
2012-12-13 |
4 |
S |
$81.00 |
$175,203 |
I/I |
(2,163) |
8,966 |
|
- |
|
| Hathaway David R |
Chief Medical Officer |
• – – |
2012-12-13 |
4 |
S |
$81.10 |
$457,404 |
D/D |
(5,640) |
0 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2012-12-13 |
4 |
S |
$81.28 |
$8,825,061 |
I/I |
(108,571) |
824,922 |
|
- |
|
| Wade Denis Newell |
Director |
– • – |
2012-12-12 |
4 |
S |
$82.50 |
$27,803 |
I/I |
(337) |
11,129 |
|
- |
|
| Hathaway David R |
Chief Medical Officer |
• – – |
2012-12-12 |
4 |
S |
$81.81 |
$490,860 |
D/D |
(6,000) |
5,640 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2012-12-12 |
4 |
S |
$81.82 |
$939,294 |
I/I |
(11,480) |
933,493 |
|
- |
|
| Hathaway David R |
Chief Medical Officer |
• – – |
2012-12-11 |
4 |
S |
$82.17 |
$493,020 |
D/D |
(6,000) |
11,640 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2012-12-11 |
4 |
S |
$82.18 |
$4,549,320 |
I/I |
(55,358) |
944,973 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2012-12-10 |
4 |
S |
$83.03 |
$2,117,265 |
I/I |
(25,500) |
1,000,331 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2012-12-07 |
4 |
S |
$80.20 |
$3,862,886 |
I/I |
(48,130) |
1,025,831 |
|
- |
|
| Thomas Robert Bain |
Director |
– • – |
2012-12-04 |
4 |
S |
$80.36 |
$289,296 |
D/D |
(3,600) |
12,677 |
|
- |
|
| Thomas Robert Bain |
Director |
– • – |
2012-12-03 |
4 |
S |
$80.60 |
$112,840 |
D/D |
(1,400) |
16,277 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2012-12-03 |
4 |
AS |
$81.21 |
$204,315 |
D/D |
(2,500) |
5,017 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2012-12-03 |
4 |
S |
$80.26 |
$113,407 |
D/D |
(1,413) |
21,232 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2012-11-21 |
4 |
AS |
$81.77 |
$67,175 |
D/D |
(800) |
7,517 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2012-11-21 |
4 |
AS |
$81.78 |
$320,512 |
D/D |
(3,817) |
62,582 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2012-11-21 |
4 |
AS |
$81.78 |
$76,327 |
D/D |
(909) |
22,645 |
|
- |
|
| Farrell Lauren |
VP, Finance |
• – – |
2012-11-21 |
4 |
AS |
$81.77 |
$46,087 |
D/D |
(536) |
676 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2012-11-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,786 |
8,317 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2012-11-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,572 |
66,399 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2012-11-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,322 |
23,554 |
|
- |
|
| Farrell Lauren |
VP, Finance |
• – – |
2012-11-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
536 |
1,212 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2012-11-01 |
4 |
AS |
$84.01 |
$84,010 |
D/D |
(1,000) |
6,531 |
|
- |
|
| Farrell Lauren |
VP, Finance |
• – – |
2012-09-18 |
4 |
AS |
$91.93 |
$6,378 |
D/D |
(69) |
676 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2012-09-18 |
4 |
AS |
$91.94 |
$84,584 |
D/D |
(915) |
7,531 |
|
- |
|
776 Records found
|
|
Page 16 of 32 |
|
|
